Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trichuris suis ova therapy for relapsing multiple sclerosis – safety study
2008-007549-29Phase 2Completed
- Sponsor
- Danish Multiple Sclerosis Research Center
- Start
- May 2009
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of trichuris suis ova in multiple sclerosis (MS), sponsored by Danish Multiple Sclerosis Research Center. Primary endpoint: Standard safety parameters. Started May 2009; status: completed.
02
Drugs
trichuris suis ova
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2008-007549-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007549-29.